Literature DB >> 18468855

A five-point change in Modified Mini-Mental State Examination was clinically meaningful in community-dwelling elderly people.

Melissa K Andrew1, Kenneth Rockwood.   

Abstract

OBJECTIVE: To determine what change in the Modified Mini-Mental State Examination (3MS), a validated and widely used cognitive screening tool for which meaningful change scores have not been clearly characterized, should be considered meaningful. STUDY DESIGN AND
SETTING: The 3MS was administered at baseline after 5 and 10 years, as part of the population-based Canadian Study of Health and Aging. We calculated Cohen's effect sizes to estimate detectable changes in 3MS screening scores over 5 and 10 years in this large and representative study sample.
RESULTS: A total of 3,255 older adults who were community dwelling at baseline completed the 3MS as part of a screening interview at all three interviews. Mean 3MS score was 90.4 (standard deviation [SD] 6.9) at t(1), 89.1 (SD 8.2) at 5 years, and 85.8 (SD 13.0) at 10 years. A change of just over one point, over 5 and 10 years, represented a clinically detectable change with a medium effect size (Cohen's d=0.5).
CONCLUSIONS: Although a change of >or=1 point was clinically detectable, consideration of additional criteria for clinical meaningfulness suggested that a change of >or=5 points likely represents a clinically meaningful difference for groups, and is a reasonable choice of cutoff in studies using the 3MS to define cognitive change in individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18468855     DOI: 10.1016/j.jclinepi.2007.10.022

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  24 in total

1.  Development and validation of risk index for cognitive decline using blood-derived markers.

Authors:  Jasmine Nettiksimmons; Hilsa Ayonayon; Tamara Harris; Caroline Phillips; Caterina Rosano; Suzanne Satterfield; Kristine Yaffe
Journal:  Neurology       Date:  2015-01-21       Impact factor: 9.910

2.  Anxiety symptoms and risk of cognitive decline in older community-dwelling men.

Authors:  Ahmed M Kassem; Mary Ganguli; Kristine Yaffe; Joseph T Hanlon; Oscar L Lopez; John W Wilson; Jane A Cauley
Journal:  Int Psychogeriatr       Date:  2017-04-09       Impact factor: 3.878

3.  The Influence of Exercise on Cognitive Function in Older Hispanic/Latino Adults: Results From the "¡Caminemos!" Study.

Authors:  Lissette M Piedra; Flavia C D Andrade; Rosalba Hernandez; Seth William Boughton; Laura Trejo; Catherine A Sarkisian
Journal:  Gerontologist       Date:  2017-11-10

4.  Arterial stiffness and cognitive decline in well-functioning older adults.

Authors:  Nora L Watson; Kim Sutton-Tyrrell; Caterina Rosano; Robert M Boudreau; Susan E Hardy; Eleanor M Simonsick; Samer S Najjar; Lenore J Launer; Kristine Yaffe; Hal H Atkinson; Suzanne Satterfield; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

5.  Executive function, memory, and gait speed decline in well-functioning older adults.

Authors:  N L Watson; C Rosano; R M Boudreau; E M Simonsick; L Ferrucci; K Sutton-Tyrrell; S E Hardy; H H Atkinson; K Yaffe; S Satterfield; T B Harris; A B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-25       Impact factor: 6.053

6.  Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures.

Authors:  A Mitnitski; N Fallah; M R H Rockwood; K Rockwood
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

7.  Decreased physical activity predicts cognitive dysfunction and reduced cerebral blood flow in heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Neurol Sci       Date:  2014-02-18       Impact factor: 3.181

8.  Pulse wave velocity and cognitive decline in elders: the Health, Aging, and Body Composition study.

Authors:  Adina Zeki Al Hazzouri; Anne B Newman; Eleanor Simonsick; Kaycee M Sink; Kim Sutton Tyrrell; Nora Watson; Suzanne Satterfield; Tamara Harris; Kristine Yaffe
Journal:  Stroke       Date:  2013-01-15       Impact factor: 7.914

9.  Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Authors:  Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer
Journal:  Arch Neurol       Date:  2009-11

10.  Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.

Authors:  Ruth Peters; Nigel Beckett; Robert Beardmore; Rafael Peña-Miller; Kenneth Rockwood; Arnold Mitnitski; Shahrul Mt-Isa; Christopher Bulpitt
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.